|
Sign In to gain access to subscriptions and/or personal tools.
|
Brachial Artery Flow-Mediated Vasodilation in Patients With Cardiac Syndrome X
Ai-Hsien Li,
Bai-Chin Lee,
Kuo-Chin Chen,
Ching-Sung Weng*,
and
Shu-Hsun Chu
* To whom correspondence should be addressed. E-mail: csw{at}be.cycu.edu.tw.
 |
Abstract |
|---|
Cardiac syndrome X (CSX) differs from coronary artery disease (CAD) and is characterized by angina, positive stress test, and patent coronary arteries. The probable mechanism is a microvascular disorder associated with endothelial dysfunction. In this study, brachial artery flow-mediated vasodilation was used as well as the endothelin-1 assay to assess endothelial function in patients with cardiac syndrome X (CSX), coronary artery disease (CAD), and healthy controls. All subjects underwent a 2-step brachial artery flow-related vasodilatation test. Serum endothelin-1, one of the most potent constricting factors, was measured for all participants. Patients with CSX had a lower brachial artery dilation ratio than controls but higher than that of CAD patients. Control subjects and CSX patients had higher endothelin-1 levels than CAD patients. CSX patients were found to have worse endothelial function than healthy volunteers, but patients with CAD had even worse endothelium function than CSX patients.
First published on April 2, 2008, doi:10.1177/0003319707308032
Angiology 2008;59:581.
A more recent version of this article appeared on October 1, 2008

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|